Trial Profile
Efficacy and safety of nab-Paclitaxel in patients with metastatic breast cancer in a real-world setting.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2015
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 11 May 2015 New trial record